Richard Frank Richter

Academic Staff

Technische Universität Dresden
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Bioprinting, a technology with the potential to support long-term space missions, offers medical solutions for human settlements on the Moon and Mars. Moreover, ‘green bioprinting’ presents a promising approach to address terrestrial environmental challenges. Effective and cost-efficient implementation of this technology beyond the Earth requires leveraging in situ resources on celestial bodies. Consequently, this study examines the integration of Lunar and Martian regolith into bioprintable hydrogels as mechanically stabilizing and protective components as well as nutrient sources. Hydrogel blends composed of alginate and methylcellulose were supplemented with regolith simulants. Rheological characterization revealed maintenance of shear thinning and shear recovery properties, ensuring optimal printability. In regards to cultivation of microalgae, the ion release/uptake of the regolith simulants in culture medium was investigated, indicating that regolith has potential to serve as nutrient source. The microalga Chlorella vulgaris and bacteria Buttiauxella sp . MASE-IM-9 and Salinisphaera shabanensis were bioprinted in regolith-based inks. Results demonstrate that the microalgae maintained their photosynthetic efficiency in regolith-containing bioinks during cultivation, exhibiting high viability and growth. The bacteria exhibited an enhanced resistance to desiccation as well as temperature and radiation stress when regolith simulants were present in the hydrogels. This study confirms the feasibility of employing Lunar and Martian regolith simulants in bioinks for green bioprinting and bacterial bioprinting. Such an approach could minimize the volume of stored printing materials and culture media, optimizing rocket transport capacity.

Year:

2026

Multiple drug‐resistant bacteria are a growing life‐threatening problem and novel treatment strategies are urgently needed. One promising option is the use of lytic bacteriophages, viruses that infect and kill bacteria with high specificity. To efficiently utilize bacteriophage therapy for the treatment of implant‐associated infections, an effective strategy for the local, long‐lasting administration of bacteriophages at the site of infection is required. With the aim of developing a defined delivery system, this study investigates the feasibility of 3D extrusion printing of bacteriophages embedded in biomaterial inks by using a Staphylococcus aureus ‐specific phage strain as model. It is demonstrated that a bacteriophage‐loaded hydrogel blend consisting of alginate and methylcellulose (AlgMC) can be printed with high shape fidelity. After cross‐linking, the hydrogel constructs release bacteriophages that maintain their activity against S. aureus over a period of 35 days when incubated in human‐plasma‐like medium (HPLM). The integration of the nanoclay Laponite into the AlgMC blend, known for its high binding capacity for biomolecules, does not further prolong the release under (near) physiological conditions in HPLM but may protect bacteriophages under nonphysiological conditions. In conclusion, bacteriophage‐loaded AlgMC inks fulfill the requirements for local bacteriophage therapy as they release active bacteriophages in a sustained manner.

Year:

2026

To achieve bone regeneration in critical size defects, filling of the defect either with autologous bone or with a biodegradable bone substitute material possessing osteoconductivity and osteoinductivity is required. Biomimetically mineralized collagen is a nanocomposite material that closely resembles the natural bone matrix in composition and structure and has proven potential for filling bone defects. Since the mineral phase hydroxyapatite can bind proteins, the aim of the present study was to explore this biomaterial as a delivery system for the osteoinductive factor bone morphogenetic protein‐2 (BMP‐2) and to investigate the dependence of BMP‐2 release on the mineral content. Three‐dimensional scaffolds with varying mineral content were prepared by blending biomimetically mineralized collagen and non‐mineralized collagen suspensions, followed by freeze‐drying and chemical crosslinking. While the average pore size decreased, the stiffness of the scaffolds increased with increasing mineral content; all scaffold variants exhibited a fundamentally elastic behavior. After loading, the release of BMP‐2 was investigated over 28 days. A significant influence of the mineral content on the release kinetics of BMP‐2 was observed—the higher the mineral content, the stronger the retention of BMP‐2 in the scaffolds. In contrast, the release of the vascular growth factor‐A (VEGF‐A), which was examined for comparison, was hardly influenced by the mineral content, indicating a low retention of VEGF‐A by binding to the mineral phase. In summary, adjustment of the mineral content opens up the possibility of controlling the release of BMP‐2 in a customized manner, but this is not transferable to VEGF‐A.

Year:

2026

Year:

2026

The prospects of fabricating human tissue grafts or models using cell‐laden bioresins in space have garnered significant interest in recent years. While there is tremendous progress in extrusion or light‐based bioprinting in microgravity conditions, printing of aligned tissues (e.g., muscle, tendon, cardiac, etc.) remains a challenge. Furthermore, current photoresin formulations do not allow long‐term cell encapsulation and are difficult to handle in microgravity conditions. In this study, a new gravity‐independent filamented light (G‐FLight) biofabrication system, which can create viable muscle constructs within seconds, is demonstrated. New photoresin formulations based on gelatin methacrylate (GelMA) for encapsulation of primary cells (murine myoblasts) and storage in printing cuvettes for at least a week at 4 °C or ‐80 °C are also demonstrated. The tissues printed in microgravity based on the new formulations exhibit higher cell viability, number of proliferating cells, and higher numbers of myotubes and fusion index compared to control formulations (i.e., GelMA dissolved in phosphate‐buffered saline). Importantly, the microgravity‐printed tissues also featured similar myotube density and fusion index to those printed using the same resins on‐ground. The G‐Flight printing concept, together with the new resins enabling refrigeration or cryopreservation with encapsulated cells, offers a promising solution for biofabrication in space.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Stefan Zwingenberger

University Medicine Greifswald

GERMANY
View details

Markus Rupp

Group Leader

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details

Ori Bar-Nur

Associate Professor

ETH Zürich

SWITZERLAND
View details

Parth Chansoria

Senior Scientist

ETH Zürich

SWITZERLAND
View details

Anne Bernhardt

University Hospital Carl Gustav Carus

GERMANY
View details

Hugo Oliveira

Inserm U1026, Tissue Bioengineering

FRANCE
View details

Vera Hintze

Technische Universität Dresden

GERMANY
View details

Michael Gelinsky

Head, Professor

Technische Universität Dresden

GERMANY
View details

Marcy Zenobi-Wong

ETH-Bereich Hochschulen

SWITZERLAND
View details